drugset / Trial / NCT00794131
Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to determine whether, GL-ONC1, an Oncolytic Virus, can safely be administered intravenously in patients with advanced solid tumors.
Timeline
- Start
- 2008-11
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olvimulogene nanivacirepvec | Other / unclassified | — | Intravenous |